ClinicalTrials.gov
ClinicalTrials.gov Menu

Emotional Reaction and Self Injury in Patients With Borderline Personality Disorder and Healthy Controls

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03149926
Recruitment Status : Not yet recruiting
First Posted : May 11, 2017
Last Update Posted : May 12, 2017
Sponsor:
Information provided by (Responsible Party):
Katharina Bachmann, University of Oldenburg

Brief Summary:
The current study investigates the emotional response of patients with borderline personality disorder and healthy controls on stimuli associated with self-injury.

Condition or disease Intervention/treatment
Borderline Personality Disorder Emotions Other: Stimuli presentation

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Other
Time Perspective: Other
Official Title: Emotional Reaction of Patients With Borderline Personality Disorder (BPD)on Stimuli Connected to Self-injury - A Comparison Between Patients With BPD and a Healthy Control Group.
Estimated Study Start Date : June 2017
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : February 2018

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Patients with Borderline Personality Disorder Other: Stimuli presentation
Different stimuli associated with self-injury are presented. Participants have to rate the emotional effect elected by the stimuli.

Healthy controls Other: Stimuli presentation
Different stimuli associated with self-injury are presented. Participants have to rate the emotional effect elected by the stimuli.




Primary Outcome Measures :
  1. Emotional reaction [ Time Frame: one session of 90min ]

    Patients comparded to healthy controls will show a stronger emotional reaction on the stimuli.

    Patients more severely affected will show a stronger emotional reaction compared to less affected patients.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients with Borderline personality disorder that are current in treatment in the inpatient dialectical behavioral therapy unit of the universityhospitel or have completed the treatment.

Matched, healthy controls without psychiatric disorders

Criteria

Inclusion Criteria:

  • Patients that are able to use skills and have some therapy experiences.

Exclusion Criteria:

  • Severe psychiatric comorbidity e.g. psychosis, severe depression, suicidality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03149926


Contacts
Contact: Katharina Bachmann, Psych.Msc. 00494119615 1506 Katharina.Bachmann@uni-oldenburg.de

Locations
Germany
Department of Psychiatry and Psychotherapy - University Hospital, University of Oldenburg
Bad Zwischenahn, Germany, 26160
Sponsors and Collaborators
Katharina Bachmann
Investigators
Principal Investigator: Alexandra Philipsen, Prof. Department of Psychiatry and Psychotherapy - University Hospital, University of Oldenburg, Oldenburg, Germany

Responsible Party: Katharina Bachmann, Psychologist Msc., University of Oldenburg
ClinicalTrials.gov Identifier: NCT03149926     History of Changes
Other Study ID Numbers: UOldenburg2
First Posted: May 11, 2017    Key Record Dates
Last Update Posted: May 12, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Disease
Personality Disorders
Borderline Personality Disorder
Self-Injurious Behavior
Pathologic Processes
Mental Disorders
Behavioral Symptoms